Department of Interventional Cardiology, Heart Hospital Baylor Plano, Plano, Texas, USA.
Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):586-597. doi: 10.1002/ccd.28887. Epub 2020 Apr 21.
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is highly infectious, carries significant morbidity and mortality, and has rapidly resulted in strained health care system and hospital resources. In addition to patient-related care concerns in infected individuals, focus must also relate to diminishing community spread, protection of staff, case selection, and concentration of resources. The current document based on available data and consensus opinion addresses appropriate catheterization laboratory preparedness for treating these patients, including procedure-room readiness to minimize external contamination, safe donning and doffing of personal protective equipment (PPE) to eliminate risk to staff, and staffing algorithms to minimize exposure and maximize team availability. Case selection and management of both emergent and urgent procedures are discussed in detail, including procedures that may be safely deferred or performed bedside.
新型冠状病毒，即严重急性呼吸系统综合征冠状病毒 2 型（SARS-CoV-2），具有高度传染性，可导致严重发病率和死亡率，并迅速导致医疗系统和医院资源紧张。除了关注受感染者的相关护理问题，还必须关注社区传播的减少、工作人员的保护、病例选择和资源集中。本文件基于现有数据和共识意见，针对治疗这些患者的导管室（心导管室）准备情况提出了相关建议，包括准备手术间以最大程度减少外部污染、安全穿戴和脱下个人防护设备（PPE）以消除工作人员的风险，以及人员配备算法，以尽量减少暴露并最大限度地提高团队的可用性。详细讨论了紧急和紧急情况下的病例选择和管理，包括可安全推迟或在床边进行的操作。
